Clinical research disruption in the post-COVID-19 era: will the pandemic lead to change?

Affiliations

¹ Scientific Directoracte and Gynecologic Oncology Unit, Department of Women and Child Health, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Lazio, Italy. Electronic address: domenica.lorusso@policlinicogemelli.it.
² Medical Oncology Department, Centre Leon Berard nd University Claude Bernard, Lyon, France.
³ Department of Oncology,Institute of Oncology, Vall d'Hebron University Hospital, Barcelona, Catalunya, Spain.
⁴ MBBS MA FRCP, The Royal Marsden NHS Foundation Trust nd Institute of Cancer Research, London, UK.

Editorial

Domenica Lorusso et al. ESMO Open. 2020 Oct.

. 2020 Oct;5(5):e000924.

doi: 10.1136/esmoopen-2020-000924.

¹ Scientific Directoracte and Gynecologic Oncology Unit, Department of Women and Child Health, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Lazio, Italy. Electronic address: domenica.lorusso@policlinicogemelli.it.
² Medical Oncology Department, Centre Leon Berard nd University Claude Bernard, Lyon, France.
³ Department of Oncology,Institute of Oncology, Vall d'Hebron University Hospital, Barcelona, Catalunya, Spain.
⁴ MBBS MA FRCP, The Royal Marsden NHS Foundation Trust nd Institute of Cancer Research, London, UK.

No abstract available

Keywords: clinical research; pandemic telemedicine; remote monitoring disruption.

Conflict of interest statement

Competing interests: None declared.

1. Liang W., Guan W., Chen R., et al. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol. 2020;21:335–337. http://www.ncbi.nlm.nih.gov/pubmed/32066541 doi:10.1016/S1470-2045(20)30096-6 - DOI - PMC - PubMed
1. Ueda M., Martins R., Hendrie P.C., et al. Managing cancer care during the COVID-19 pandemic: Agility and collaboration toward a common goal. J Natl Compr Canc Netw. 2020:366–369. http://www.ncbi.nlm.nih.gov/pubmed/32197238 doi:10.6004/jnccn.2020.7560 - DOI - PubMed
1. Tagliamento M., Lambertini M., Genova C., et al. Call for ensuring cancer care continuity during COVID-19 pandemic. ESMO Open. 2020;5 http://www.ncbi.nlm.nih.gov/pubmed/32381594 doi:10.1136/esmoopen-2020-000783 - DOI - PMC - PubMed
1. Poggio F., Tagliamento M., Di Maio M., et al. Assessing the impact of the COVID-19 outbreak on the attitudes and practice of Italian oncologists toward breast cancer care and related research activities. JCO Oncol Pract. 2020 http://www.ncbi.nlm.nih.gov/pubmed/32574131 doi:10.1200/OP.20.00297 OP.20.00297. - DOI - PubMed
1. Hollander J.E., Carr B.G. Virtually perfect? telemedicine for Covid-19. N Engl J Med. 2020;382:1679–1681. http://www.ncbi.nlm.nih.gov/pubmed/32160451 doi:10.1056/NEJMp2003539 - DOI - PubMed